Multimodal Information-Driven Heterogeneous Graph Neural Networks for Protein–Ligand Binding Affinity Prediction
Journal of Chemical Information and Modeling · 10.08.2026 · 66 (15) · 9663-9680
DOI: 10.1021/acs.jcim.6c01317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 16.06.2026. Verfasst von Bin Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Artificial Intelligence and Data Science, University of Science and Technology of China, Hefei230027, China. Hauptthemen laut MEDLINE: Graph Neural Networks, Proteins. Die Arbeit nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Accurate prediction of protein–ligand binding affinity (PLA) is essential for efficient drug screening. However, existing methods often inadequately model multimodal molecular interactions and their combined effects on binding affinity. To address this challenge, this study introduces AtomBind, a multimodal information-driven heterogeneous graph neural network framework. First, an atomic-level heterogeneous graph is constructed, integrating sequence information, 3D structure, geometric constraints, and molecular representations generated by pretrained protein and chemical language models. Second, the Intra Encoder utilizes a variational graph autoencoder and equivariant graph neural network architecture to capture complex topological relationships at the molecular scale, addressing short-range atomic dependencies and dynamic structural variations. Finally, the Inter Encoder incorporates graph diffusion convolution and graph Transformer architectures, facilitating cross-molecular information transfer between protein pockets and ligands while simultaneously capturing both global and local intermolecular interaction features. Comparative experiments demonstrate that AtomBind exhibits superior predictive consistency and smaller errors compared to other models on two test sets. Ablation studies and pretrained language model analysis further validate the efficiency and robustness of AtomBind in multimodal information integration and affinity prediction. Additionally, the model demonstrates strong generalization capabilities and broad practical application potential in analyzing protein pockets, intermolecular interactions, and interpretability analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Artificial Intelligence and Data Science, University of Science and Technology of China, Hefei230027, China.
- School of Data Science, Qingdao University of Science and Technology, Qingdao266061, China.
- Computational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal23955, Saudi Arabia.
- School of Computer Science and Technology, University of Science and Technology of China, Hefei230027, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yu, B., He, S., Li, Y., Gao, X., & Lian, D. (2026). Multimodal Information-Driven Heterogeneous Graph Neural Networks for Protein–Ligand Binding Affinity Prediction. Journal of Chemical Information and Modeling, 66(15), 9663-9680. https://doi.org/10.1021/acs.jcim.6c01317
Vancouver
Yu B, He S, Li Y, Gao X, Lian D. Multimodal Information-Driven Heterogeneous Graph Neural Networks for Protein–Ligand Binding Affinity Prediction. Journal of Chemical Information and Modeling. 2026;66(15):9663-9680. doi:10.1021/acs.jcim.6c01317
BibTeX
@article{Yu2026,
author = {Yu, Bin and He, Shiyue and Li, Ya and Gao, Xin and Lian, Defu},
title = {Multimodal Information-Driven Heterogeneous Graph Neural Networks for Protein–Ligand Binding Affinity Prediction},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
volume = {66},
number = {15},
pages = {9663--9680},
doi = {10.1021/acs.jcim.6c01317}
}
EUVIMED